Gender-affirming hormone therapy does not need to be a strict contraindication in transgender patients with rheumatic disease, an author of a new case series and systematic review said.
Serious infections declined from 2012 to 2017 among patients with PsA in the National Inpatient Sample, but the study relied only on hospital discharge records, and other infections and could have been missed.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows significant decreases in infections among people with psoriatic arthritis over the years 2012-2017.